VDP-157: Develop VitaDAO’s first longevity product
Voting closed | 2,102,196 Total Votes
VDP 154 - Designate VitaDAO as a Vitalist Organization
Voting closed | 1,171,550 Total Votes
VDP - 155 Approving Genesis Guardians for VitaDAO 2.0
Voting closed | 5,092,384 Total Votes
VDP-153 [Funding] Project Ab4AD: Identifying Protective Antibodies Against Alzheimer's Disease
Voting closed | 2,215,978 Total Votes
VDP-146 [Funding] The development of oligonucleotide drugs for healthspan
Voting closed | 891,963 Total Votes
VDP-148 Blueprint for Sustainable Growth: Operationalizing VitaDAO’s New Mandate
Voting closed | 5,426,258 Total Votes
VDP-139 [Funding] Luminova: mtON gene therapy in the aged eye
Voting closed | 2,296,156 Total Votes
VDP-147: Catalyst Beta Program: Funding Experiment for Longevity Research Moonshots
Voting closed | 1,901,709 Total Votes
VDP-133 - VITA-FAST Genesis contributor allocation proposal
Voting closed | 3,391,050 Total Votes
VDP-136 Proposal: Compensation Policy Squad Update to VDP-72
Voting closed | 2,008,245 Total Votes
VDP-132 [Funding] Mario Cordero - Multi-inflammasome inhibitors to treat aging and age-related diseases
Voting closed | 2,611,402 Total Votes
VDP-125 - Rework - Scheibye-Knudsen Lab IP-NFT Asset
Voting closed | 2,885,701 Total Votes
VDP-130 [Governance]: VITA-FAST Community Growth and Operational Support Proposal
Voting closed | 1,899,674 Total Votes
VDP-129 [Assessment]: Vitalia - a city that builds longevity companies
Voting closed | 2,572,064 Total Votes
VDP-121 Proposal to Mint up to 10% of Total Token Supply
Voting closed | 1,924,220 Total Votes
VDP-120 [Assessment]: Oisín Biotechnologies - Genetic Medicines for Health and Longevity
Voting closed | 2,252,210 Total Votes
VDP-118 [Assessment]: GERO - Machine Learning Platform for Age-Related Disease Targeting & Drug Discovery
Voting closed | 2,684,870 Total Votes
VDP-119 Proposal to Empower Member Services Squad
Voting closed | 2,968,170 Total Votes
VDP-112 [Assessment] Cyclarity - Novel cyclodextrin molecules for multiple aging-related diseases
Voting closed | 3,417,553 Total Votes
VDP-90 [Assessment] MutagenTech - Somatic mutation sequencing technology
Voting closed | 2,069,745 Total Votes
VDP-103 [Funding]: Mutation-Specific Codon Suppression for Aging and Longevity
Voting closed | 2,961,384 Total Votes